181 related articles for article (PubMed ID: 22792244)
1. Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control studies.
Wang L; Wang G; Lu C; Feng B; Kang J
PLoS One; 2012; 7(7):e40219. PubMed ID: 22792244
[TBL] [Abstract][Full Text] [Related]
2. The E-cadherin gene polymorphism 160C->A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies.
Wang GY; Lu CQ; Zhang RM; Hu XH; Luo ZW
Am J Epidemiol; 2008 Jan; 167(1):7-14. PubMed ID: 17971340
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.
Chang Z; Zhou H; Liu Y
Tumour Biol; 2014 Oct; 35(10):10503-13. PubMed ID: 25056535
[TBL] [Abstract][Full Text] [Related]
4. CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer.
Chen B; Zhou Y; Yang P; Liu L; Qin XP; Wu XT
Cytokine; 2011 Aug; 55(2):266-73. PubMed ID: 21570316
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects.
Ye CC; Wang J
J Gene Med; 2021 Oct; 23(10):e3370. PubMed ID: 34097324
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X
Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
[TBL] [Abstract][Full Text] [Related]
8. Association between the Epithelial Cadherin - 160C/A Polymorphism and Colorectal Cancer Risk: Evidence from a Meta-Analysis.
Sun N; Chen J; Hu G; Chen X; Jiang J; Zhang L; Wu H
Crit Rev Eukaryot Gene Expr; 2017; 27(4):347-354. PubMed ID: 29283329
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
[TBL] [Abstract][Full Text] [Related]
10. Association between the epithelial cadherin -160C/A gene polymorphism and diffuse gastric cancer risk: a meta-analysis.
Chen XW; Sun JX; Wang ZN; Gao P; Song YX; Cao JF; Liu B; Xu HM
Genet Mol Res; 2014 Feb; 13(1):850-9. PubMed ID: 24615049
[TBL] [Abstract][Full Text] [Related]
11. The epithelial cadherin -160C/A polymorphism is associated with decreased risk of colorectal cancer: a case-control study.
Li W; Xiao D; Wu H; Xu L
Clin Exp Med; 2020 Feb; 20(1):73-78. PubMed ID: 31625007
[TBL] [Abstract][Full Text] [Related]
12. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
[TBL] [Abstract][Full Text] [Related]
13. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
[TBL] [Abstract][Full Text] [Related]
14. -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.
Jonsson BA; Adami HO; Hägglund M; Bergh A; Göransson I; Stattin P; Wiklund F; Grönberg H
Int J Cancer; 2004 Apr; 109(3):348-52. PubMed ID: 14961571
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients.
Li HC; Albert JM; Shinohara ET; Cai Q; Freyer A; Cai H; Cao C; Wang Z; Kataoka N; Teng M; Zheng W; Lu B
Urol Oncol; 2006; 24(6):496-502. PubMed ID: 17138130
[TBL] [Abstract][Full Text] [Related]
17. Roles of E-cadherin (CDH1) genetic variations in cancer risk: a meta-analysis.
Deng QW; He BS; Pan YQ; Sun HL; Xu YQ; Gao TY; Li R; Song GQ; Wang SK
Asian Pac J Cancer Prev; 2014; 15(8):3705-13. PubMed ID: 24870781
[TBL] [Abstract][Full Text] [Related]
18. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
Ben Nasr H; Hamrita B; Batbout M; Gabbouj S; Bouaouina N; Chouchane L; Chahed K
Clin Chim Acta; 2010 Sep; 411(17-18):1253-7. PubMed ID: 20462505
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis.
Wang Y; Yang H; Li L; Wang H; Zhang C; Xia X
Int J Colorectal Dis; 2012 Feb; 27(2):151-8. PubMed ID: 21997289
[TBL] [Abstract][Full Text] [Related]
20. The CDH1 -160C/A polymorphism is associated with breast cancer: evidence from a meta-analysis.
Ma YY; Wu WQ; Liu ZC; Yu XF; Guo K; He QW; Jiang SB; Shao QS; Tao HQ; Huang DS
World J Surg Oncol; 2016 Jun; 14(1):169. PubMed ID: 27349965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]